Legend Biotech appoints Novartis veteran Ingrid Zhang as CEO
Legend Biotech (NASDAQ:LEGN) appointed longtime Novartis executive Ingrid Zhang as CEO, effective immediately.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Legend Biotech appoints Ingrid Zhang as CEO
Content provided by Seeking Alpha is intended for information purposes only, and that Seeking Alpha does not offer any personalist investment advice and is not a licensed securities dealer, broker, US investment adviser or investment bank.
Legend Biotech Corporation Appoints Ingrid Zhang CEO
Legend Biotech appointed Ingrid Zhang as Chief Executive Officer, effective Sept. 15, 2026. Alan Bash resumes his role as President, CARVYKTI.Material DetailsContext by AI AnalystThis is a leadership transition following an interim CEO period, signaling the next phase for a commercial-stage cell th…
Legend Biotech Appoints Ingrid Zhang as CEO >LEGN
Legend Biotech Appoints Ingrid Zhang as CEO >LEGN